Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
5(63%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
13%
Ph phase_2
2
25%
Ph not_applicable
2
25%
Ph phase_3
3
38%

Phase Distribution

1

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
Phase 2Efficacy & side effects
2(25.0%)
Phase 3Large-scale testing
3(37.5%)
N/ANon-phased studies
2(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

8

all time

Status Distribution
Active(6)
Completed(2)

Detailed Status

Recruiting4
Completed2
Not yet recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
5
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (12.5%)
Phase 22 (25.0%)
Phase 33 (37.5%)
N/A2 (25.0%)

Trials by Status

not_yet_recruiting113%
recruiting450%
completed225%
active_not_recruiting113%

Recent Activity

5 active trials
Showing 5 of 8
recruitingphase_2

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

NCT05640999
recruitingnot_applicable

Postoperative Hypofractionated Radiation in Cervical and Endometrial Tumours: Phase II Study

NCT05857631
recruitingnot_applicable

PROfiling Based Endometrial Cancer Adjuvant Therapy

NCT05179447
recruitingphase_2

Refining Adjuvant Treatment in Endometrial Cancer Based on Molecular Features

NCT05255653
active_not_recruitingphase_3

PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer

NCT03469674
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT05640999Phase 2

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

Recruiting
NCT05857631Not Applicable

Postoperative Hypofractionated Radiation in Cervical and Endometrial Tumours: Phase II Study

Recruiting
NCT05179447Not Applicable

PROfiling Based Endometrial Cancer Adjuvant Therapy

Recruiting
NCT05255653Phase 2

Refining Adjuvant Treatment in Endometrial Cancer Based on Molecular Features

Recruiting
NCT03469674Phase 3

PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer

Active Not Recruiting
NCT05524389Phase 3

Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions

Not Yet Recruiting
NCT00376844Phase 3

External-Beam Radiation Therapy Compared With Vaginal Brachytherapy After Surgery for Stage I Endometrial Cancer

Completed
NCT00448643Phase 1

Whole-Abdominal Radiation Therapy and Cisplatin in Treating Patients With Stage III or Stage IV Endometrial Cancer That Has Been Removed by Surgery

Completed

All 8 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
8